Venkat Krishnamurthy, Ph.D., is senior vice president and head of platform at Korro Bio, with over 12+ years of experience in RNA based therapeutics, oligonucleotide chemistry and non-viral delivery technologies.
Before arriving at Korro, Dr. Krishnamurthy held an executive director role at Eli Lilly & Company, where he was responsible for strategic direction for Lilly’s genetic medicine portfolio. Prior to this, Dr. Krishnamurthy was a team lead at AstraZeneca, where he built a new...Read more